The effect of 1-week treatment with permitted inhalation or prohibited oral doses of salbutamol on repeated sprint ability in healthy well-trained men and women

Background: Beta2-agonists are frequently used in treatment of asthma and exercise-induced bronchoconstriction. There is an ongoing debate whether beta2-agonists are performance enhancing. The aim of the present study was to investigate the effect of 1-week treatment with permitted inhalation or prohibited oral ingestion of salbutamol on repeated sprint ability. Methods: Twenty non-asthmatic well-trained young men (n =10) and women...